2021 Global Cell Therapy Manufacturing Market Report, Major Players KBI Biopharma, Waisman Biomanufacturing, Merck and Thermo Fisher Scientific

Dublin, November 26, 2021 (GLOBE NEWSWIRE) – The Global Cell Therapy Manufacturing Market, by Treatment (T-Cell Therapies, Stem Cell Therapies, Cancer Cell Therapies, Stem Cell Therapies), By Cell Source, By Process Scale, By Source, By Application, End User, By Region, Competition Forecast And Opportunities, 2026″ Report added to ResearchAndMarkets.com an offer.

The global cell therapy manufacturing market is expected to grow in the forecast period, 2022-2026 at an impressive CAGR.

The growth of the market can be attributed to the rapid growth of biopharmaceutical industries across the globe. The development of cutting-edge therapies and paradigm shifting for many life-threatening diseases will lead to the growth of the global cell therapy manufacturing market in the next five years.

The ongoing COVID-19 pandemic has played an important role in the growth of the global cell therapy manufacturing market. The healthcare industry has been involved in extensive research and technological developments that have led to advanced medicine and treatment facilities for patients. The urgent need for effective treatments as well as a vaccine against infection has supported the exponential growth in the market in the past two years. The market is expected to maintain similar growth in the next five years on the same factor. Although research is constantly growing, experience in this sector is limited, and the lack of specialized infrastructure for the production of cell therapies and the development of various products may moderately constrain future growth of the market.

The global cell therapy manufacturing market is segmented on the basis of treatment, cell source, process volume, source, application, end user, competitive landscape, and regional distribution. Based on treatment, the market is further segmented into T-cell therapies, dendritic cell therapies, cancer cell therapies, and stem cell therapies. Stem cell therapy is expected to capture the largest market share and dominate the sector in the next five years at the expense of increasing research and development in the region. Stem cell therapy is used in the treatment of various chronic diseases and continuous efforts to provide the best treatment available to patients.

Additionally, the increasing number of ongoing clinical trials and growing stem cell therapy products in the market is aiding in the growth of the global cell therapy manufacturing market in the next five years. The rise in Food and Drug Administration and biopharmaceutical company approvals dedicated to the continued development of cell therapies supports the growth of the global cell therapy manufacturing market in the next five years.

Years considered in this report:

Scope of the report:

In this report, the global cell therapy manufacturing market has been segmented into the following categories, as well as industry trends which are further detailed below:

Global Cell Therapy Manufacturing Market, By Treatment:

  • T cell therapies

  • Stem cell treatments

  • Cancer cell treatments

  • Stem cell treatments

Global Cell Therapy Manufacturing Market, By Cell Source:

Global Cell Therapy Manufacturing Market, By Process Scale:

  • preclinical

  • Patients

  • commercial

Global Cell Therapy Manufacturing Market, By Source:

  • In House

  • manufacturing contract

Global Cell Therapy Manufacturing Market, By Application:

  • Oncology

  • Cardiovascular disease

  • bone diseases

Global Cellular Therapy Manufacturing Market, By End User:

mentioned companies

  • KBI Biopharma, Inc.

  • Weizmann Bio-Industries

  • Catapult of cell and gene therapy

  • Thermo Fisher Scientific, Inc.

  • Merck KGaA

  • Catalint Inc

  • Lonza group

  • Oxford Biomedica plc

  • Fujifilm Cellular Dynamics, Inc.

  • Wushi Optic

  • Charles River Laboratories International, Inc.

  • Discovery Labs LLC

  • ABL, Inc.

  • BioCentriq

  • Marketing of live treatments

For more information about this report visit https://www.researchandmarkets.com/r/onomr5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We bring you the latest data on international and regional markets, key industries, major companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Add a Comment

Your email address will not be published. Required fields are marked *